OneMedNet Corporation reports significant third quarter growth in bookings, reduced liabilities, and advancements in AI integration and subscription models.
Quiver AI Summary
OneMedNet Corporation (Nasdaq: ONMD) reported significant financial growth for the third quarter of 2025, achieving $1.1 million in bookings, a remarkable 815% increase from the same period in 2024. The company also secured an additional $0.5 million through private placements and further reduced its liabilities by $1.9 million, totaling $14.3 million for the year. Operationally, OneMedNet started a pilot program integrating Palantir’s AI platform with its iRWD™ network, enhancing data discovery and multimodal data integration. The company launched a SaaS subscription model powered by this platform, enabling dynamic access to real-world data and boosting recurring revenue. CEO Aaron Green emphasized the strategic focus on debt reduction and capital investment to drive long-term value and enhance customer insights.
Potential Positives
- Third quarter 2025 bookings reached $1.1M, marking an 815% increase compared to the same quarter in 2024, indicating strong revenue growth.
- Successfully completed a $0.5M private placement of common stock, enhancing the company's investment capacity for strategic objectives.
- Reduced total liabilities by an additional $1.9 million during the third quarter, contributing to a total reduction of $14.3 million year-to-date, thereby strengthening the company's balance sheet.
- Initiated a pilot project with Palantir's AI Platform, which aims to enhance the company's data capabilities, including faster data discovery and improved multimodal data integration, potentially increasing competitive advantage in the market.
Potential Negatives
- Despite showing an impressive increase in bookings, the press release does not provide specific metrics on overall revenue or profitability, raising concerns about the sustainability of this growth.
- The reliance on an insider for a significant private placement of common stock may raise red flags regarding the company's ability to attract external investment.
- The discussion of forward-looking statements introduces uncertainty and risks that could undermine investor confidence, emphasizing a lack of concrete future performance guarantees.
FAQ
What were OneMedNet's third quarter bookings for 2025?
OneMedNet reported $1.1 million in bookings for the third quarter of 2025, an 815% increase from 2024.
How did OneMedNet improve its balance sheet in Q3 2025?
The company reduced total liabilities by an additional $1.9 million in the third quarter, totaling $14.3 million year-to-date.
What is the new SaaS subscription model introduced by OneMedNet?
OneMedNet launched a recurring revenue model featuring Palantir-powered RWD subscriptions with Live Data Feeds and AI-Driven Conversational Search.
How is OneMedNet leveraging Palantir's AI platform?
The integration aims to enhance data discovery speed, AI-driven de-identification, and multimodal data integration.
What industries can benefit from OneMedNet's AI anonymization technology?
Besides healthcare, OneMedNet's technology offers solutions for finance, retail, and telecom sectors, enabling secure data sharing.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$ONMD Hedge Fund Activity
We have seen 11 institutional investors add shares of $ONMD stock to their portfolio, and 10 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CORRECT CAPITAL WEALTH MANAGEMENT added 4,504,955 shares (+inf%) to their portfolio in Q3 2025, for an estimated $4,910,400
- EXENCIAL WEALTH ADVISORS, LLC added 2,107,598 shares (+141.3%) to their portfolio in Q3 2025, for an estimated $2,297,281
- VANGUARD GROUP INC added 234,739 shares (+31.4%) to their portfolio in Q3 2025, for an estimated $255,865
- HRT FINANCIAL LP removed 182,638 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $199,075
- GEODE CAPITAL MANAGEMENT, LLC added 174,885 shares (+128.0%) to their portfolio in Q3 2025, for an estimated $190,624
- CKW FINANCIAL GROUP removed 100,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $57,010
- GOLDMAN SACHS GROUP INC added 56,584 shares (+inf%) to their portfolio in Q3 2025, for an estimated $61,676
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
MINNEAPOLIS, Nov. 17, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet,” the “Company,” “we,” “us” or “our”), a leader in AI-powered Real-World Data (RWD), announced its financial results for the third quarter ended September 30, 2025 and operational highlights.
Third Quarter Financial Highlights
- Bookings: $1.1M in third quarter 2025 bookings, an 815% increase compared to third quarter of 2024.
- Private Placements: Successfully completed an additional $0.5M private placement of common stock from an insider, providing further investment towards strategic objectives.
-
Further Improved Balance Sheet
: Continuing with its efforts first reported at the end of the second quarter, OneMedNet further improved its balance sheet by reducing total liabilities by an additional $1.9 million during the third quarter, with year-to-date reductions in total liabilities totaling $14.3 million.
Operational Highlights
-
Integration of Palantir’s AI Platform:
In September 2025, OneMedNet commenced a Pilot on Palantir Technologies' Artificial Intelligence Platform (AIP) to integrate with our iRWD™ network, which provided us insights on the platform capabilities including:
- Faster data discovery (in minutes rather than days);
- AI-driven de-identification for large scale orders;
- Healthcare standards integration (e.g., SNOMED, HCPCS, ICD-10, CPT); and
-
Federated search, and Multimodal data integration.
-
Rollout of SaaS Subscription Model:
OneMedNet announced the delivery of its recurring revenue model promise through Palantir-powered RWD subscriptions, featuring Live Data Feeds and AI-Driven Conversational Search.
- These offerings transform static data access into dynamic, on-demand intelligence, allowing customers to harness regulatory-grade, multimodal data for real-time insights and accelerated decision-making, bolstering the Company's recurring revenue foundation.
“ The combination of reduced debt, and strategic capital infusions enables us to focus on strategic opportunities to deliver long-term value to our customers, partners, and shareholders. Our continued focus on our strategy in the third quarter has resulted in a more resilient sales pipeline, larger deal sizes with a 4.5X increase in inbound demand, building steady momentum for OneMedNet. Additionally, by utilizing Palantir's AI Platform to enhance our scalable proven platform, we are accelerating the delivery of our subscription models, enabling faster, more efficient access to high-quality real-world data for our clients,” says Aaron Green, CEO & President of OneMedNet.
About OneMedNet Corporation
OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn’t just data—it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption.
Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities—rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com.
Cautionary Note Regarding Forward-Looking Statements
This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial and operational performance, debt reductions, and their effect on achieving operational strategies of the company. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Digital Assets, including Digital Asset’s volatility; and our ability to implement our Digital Asset treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations.
OneMedNet Contacts:
Michael Wong, VP Marketing
Email: [email protected]
SOURCE: ONEMEDNET CORPORATION